Cited by

• Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer.

  Yin X, Jiang K, Zhou Z, Yu H, Yan D, He X, Yan S. Yin X, et al. Oxid Med Cell Longev. 2023 Jan 20;2023:3878796. doi: 10.1155/2023/3878796. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 36713030 Free PMC article.
• Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.

  Malley SD, Grange JM, Hamedi-Sangsari F, Vila JR. Malley SD, et al. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11017-21. doi: 10.1073/pnas.91.23.11017. Proc Natl Acad Sci U S A. 1994. PMID: 7972000 Free PMC article.
• Stabilization of SV40 transformed human fibroblast cytoplasmic thymidine kinase by ATP.

  Porter PN, Bull D, Jones OW. Porter PN, et al. Mol Cell Biochem. 1981 Feb 26;35(1):59-64. doi: 10.1007/BF02358189. Mol Cell Biochem. 1981. PMID: 6261118
• Hydroxyurea-resistant mouse L cells with elevated levels of drug-resistant ribonucleotide reductase activity.

  Kuzik BA, Wright JA. Kuzik BA, et al. Biochem Genet. 1980 Apr;18(3-4):311-31. doi: 10.1007/BF00484244. Biochem Genet. 1980. PMID: 7004438
• Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

  Gammon DB, Gowrishankar B, Duraffour S, Andrei G, Upton C, Evans DH. Gammon DB, et al. PLoS Pathog. 2010 Jul 8;6(7):e1000984. doi: 10.1371/journal.ppat.1000984. PLoS Pathog. 2010. PMID: 20628573 Free PMC article.